Authors: Rubin, DL Desser, TS Semelka, R Brown, J Nghiem, HV Stevens, WR Bluemke, D Nelson, R Fultz, P Reimer, P Ho, V Kristy, RM Pierro, JA

Citation: Dl. Rubin et al., A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial, J MAGN R I, 9(2), 1999, pp. 240-250